NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Goslin RE, Gray RN, McCrory DC, et al. Behavioral and Physical Treatments for Migraine Headache. Rockville (MD): Agency for Health Care Policy and Research (US); 1999 Feb. (Technical Reviews, No. 2.2.)

Cover of Behavioral and Physical Treatments for Migraine Headache

Behavioral and Physical Treatments for Migraine Headache.

Show details

Appendix BData Collection Form

Data Abstraction Form

First Author (last name):__________

ver 5.19.95

Pro-Cite no.:_______

Reviewer__________

Today’s date: __/__/____

EXCLUDE Why?

Are most or all of the patients in this study in the pediatric age group (0–17)?

No

Yes

-> STOP

State the inclusion criteria (headache diagnoses first)

Headache diagnosis:

Migraine

Tension-type

Cluster

mixed

other________

Diagnostic criteria:

IHS

Ad hoc

other

none/NS

State the exclusion criteria (headache diagnoses first)

Patient enrollment site (circle all that apply)

Primary Care Clinic

General Neurology Clinic

Headache Clinic

Not Stated

Emergency Clinic

Pain Clinic

Psychology clinic

Other__________

Design:

Unclear

Single-period parallel-group

Crossover

Matched pair (or paired)

For Cross-over design only-> Was there a significant carry-over effect? Yes No Not Stated

If “yes” then abstract “period one” data only as if the trial used a parallel group design.

Instrument to measure bias in pain research reports (Jadad 1996)ResponseScore
1Was the study described as randomized (this includes the use of words such as randomly, random and randomization)?Yes
No
1
0
laIf the method of generating the randomization sequence was described, was it adequate (table of random numbers, computer- generated, coin tossing, etc.) or inadequate (alternating, date of birth, hospital number, etc.)?Not described/NA
Adequate
Inadequate
0
1
−1
2Was the study described as double-blind?Yes
No
1
0
2aIf the method of blinding was described, was it adequate (identical placebo, active placebo, etc.) or inadequate (comparison of tablet vs. injection with no double dummy)?Not described/NA
Adequate
Inadequate
0
1
−1
3Was there a description of withdrawals and drop-outs?Yes
No
1
0
Describe the elements of the study design common to all groups (eg, 4 wk lead in, 12 wk treatment period)
Brief description of interventionDetails (including dose, duration, timing, etc.)
Intervention 1 (placebo or control or wait-list)
Intervention 2
Intervention 3
Intervention 4

Patient characteristics (overall: if figures are given by treatment groups, then calculate weighted average)

Age ______±______ or ________ (__ to __)

mean ± std dev median and (lower to upper range)

Female (%) _________

Chronicity of HIA d/o (x̄ years) _____

HA frequency (#HA/mo) ________

Patient characteristics describe:

pre-treatment (trial entry)

post-treatment (completion)

Adverse Event Frequency (%)OverallIntervention 1Intervention 2Intervention 3Intervention 4
Total entered study, n
Total completed study, n
Dropouts 2° S/E, (%)
Dropouts, total, (%)
Outcome measure Primary or secondaryDef”n (e.g. from 2 or 3 to 0 or 1)How measured? (e.g. 4 pt scale)When assessed? (2 hrs, 2 mo)When were sx recorded? (daily, etc)
BEFORE/Period 1/single-period parallel-group designGp 1Gp2Gp3Gp4
Sample size
Mean
SD/VAR/SEM (circle one)
AFTER/Period 2
Sample size
Mean
SD/VAR/SEM (circle one)
BEFORE/AFTER comparisons
Mean
SD/VAR/SEM of difference (circle
Test statistic for diff
Degrees of freedom for test statistic
p-value of test statistic
Name of test statistic (e.g.; t, F, etc.)
BETWEEN GROUP COMPARISONS
Mean
SD/VAR/SEM of difference (circle
Test statistic for diff
Degrees of freedom for test statistic
p-value of test statistic
Name of test statistic (e.g.; t, F, etc.)
F statisticd.f.p-value
OVERALL COMPARISON/ANOVA
Outcome measure Primary or secondaryDef” (e.g. from 2 or 3 to 0 or 1)How measured? (e.g. 4 pt scale)When assessed? (2 hrs, 2 mo)When were sx recorded? (daily, etc)
Outcomes (fill in dichotomous outcomes, categories, or ranges for groups as column headers)Totals
worstbest
TreatmentsN(%)N(%)N(%)N(%)N(%)N (100%)
A
B
C
D
Outcome measure Primary or secondaryDef”n (e.g. from 2 or 3 to 0 or 1)How measured? (e.g. 4 pt scale)When assessed? (2 hrs, 2 mo)When were sx recorded? (daily, etc)
worstbestTotals
TreatmentsN(%)N(%)N(%)N(%)N(%)N (100%)
A
B
C
D

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (7.2M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...